Montanova Capital, LLC's Form 4 filing
Benitec Biopharma Inc. (BNTC) · filed Dec 22, 2025
- Accession no.
- 0000899140-25-001459
- Filed
- Dec 22, 2025, 7:45 PM ET
- Trade date
- Dec 18-22, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market purchases total $539.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Montanova Capital, LLCCIK 0001569064 | Director, 10% Owner |
| Averill Master Fund, Ltd.CIK 0001939329 | Director, 10% Owner |
| Averill Madison Master Fund, Ltd.CIK 0002021243 | Director, 10% Owner |
| Cowen AaronCIK 0001869640 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +8,700 | $11.24 | +$97,788 | 9,546,875 | Indirect | |
| Dec 18, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +1,515 | $11.24 | +$17,028.6 | 1,821,327 | Indirect | |
| Dec 19, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +13,950 | $11.48 | +$160,146 | 9,560,825 | Indirect | |
| Dec 19, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +2,434 | $11.48 | +$27,942.32 | 1,823,761 | Indirect | |
| Dec 22, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +16,650 | $12.08 | +$201,132 | 9,577,475 | Indirect | |
| Dec 22, 2025 | Common stock, par value $0.0001 per share | PPurchaseAcquired | +2,892 | $12.08 | +$34,935.36 | 1,826,653 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.